Post-radiotherapy, LPS (50 ng/mL in vitro) enhances antigen-specific CD8+ T cell responses and reduces MDSC infiltration, prolonging median OS in E.G7 lymphoma models (221). This evidence concerns the gene CD8A and lymphoma.